Skip to main content

Month: September 2023

W&T Offshore Announces Participation in Pareto Securities’ 30th Annual Energy Conference

HOUSTON, Sept. 14, 2023 (GLOBE NEWSWIRE) — W&T Offshore, Inc. (NYSE: WTI) today announced its participation in Pareto Securities’ 30th Annual Energy Conference in Oslo, Norway on September 20-21, 2023. Tracy Krohn, W&T’s Chairman and Chief Executive Officer, is scheduled to make a presentation on Wednesday, September 20th, 2023 at noon Oslo time. Senior management will also host one-on-one meetings with investors during the Conference. While the presentation will not be webcast, an updated investor slide deck prepared in conjunction with the Conference will be posted the day of the event in the “Investors” section of W&T’s website under “Presentations”. About W&T Offshore W&T Offshore, Inc. is an independent oil and natural gas producer with operations offshore in the Gulf of Mexico and has grown through...

Continue reading

Sunrun Prices Record-Setting $715 million Senior Securitization of Residential Solar & Battery Systems

SAN FRANCISCO, Sept. 14, 2023 (GLOBE NEWSWIRE) — Sunrun (Nasdaq: RUN), the nation’s leading provider of residential solar, storage and energy services, today announced it has priced a securitization of leases and power purchase agreements, known as Sunrun’s solar-as-a-service offering. “The capital markets continue to recognize the high quality of Sunrun’s residential solar assets, and the company’s industry-leading performance as an originator and servicer. This latest securitization sets new records, representing the largest securitization in Sunrun’s history and also the largest across the entire residential solar industry. Combined with a senior portfolio term-out financing closed in July, the Class A Notes represent over $1 billion of senior term debt financing raised this quarter, demonstrating deep access to attractively-priced...

Continue reading

Jupiter Wellness Changes its Name to Safety Shot and Ticker to “SHOT” in Alignment with New Business Focus

Safety Shot is the first patented beverage on Earth that helps a person feel better faster by reducing blood alcohol content and boosting clarity JUPITER, FL, Sept. 14, 2023 (GLOBE NEWSWIRE) — Jupiter Wellness, Inc. (Nasdaq: JUPW) (Nasdaq: SHOT) today announced that effective September 15, 2023, the Company has changed its name to Safety Shot, Inc. and at the open of market has changed its ticker symbol and will be trading as “SHOT”. The Company recently acquired Safety Shot which is going into production at facilities across the U.S. in preparation for its launch in the fourth quarter of 2023. Created by industry experts, patented, and validated by research, Safety Shot helps to break down alcohol faster while aiding in recovery and rehydration. Safety Shot is pushing the boundaries of innovation by creating an exciting new product...

Continue reading

Freehold Royalties Ltd. Declares Dividend for September 2023

CALGARY, Alberta, Sept. 14, 2023 (GLOBE NEWSWIRE) — Freehold Royalties Ltd. (Freehold) (TSX: FRU) announces that its Board of Directors has declared a dividend of Cdn. $0.09 per common share to be paid on October 16, 2023 to shareholders of record on September 29, 2023. These dividends are designated as “eligible dividends” for Canadian income tax purposes. Freehold’s focus is on acquiring and managing oil and gas royalties. Freehold’s common shares trade on the Toronto Stock Exchange in Canada under the symbol FRU. For further information, contact: Freehold Royalties Ltd.Matt DonohueManager, Investor Relations & Capital Marketst. 403.221.0833f. 403.221.0888tf. 1.888.257.1873e. mdonohue@rife.com w. www.freeholdroyalties.com

Continue reading

HeartSciences Reports First Quarter Fiscal 2024 Financial Results

Southlake, TX, Sept. 14, 2023 (GLOBE NEWSWIRE) — Heart Test Laboratories, Inc. d/b/a HeartSciences (Nasdaq: HSCS; HSCSW) (“HeartSciences” or the “Company”), an artificial intelligence (AI)-based medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease, today provided a business update and reported financial results for the first quarter fiscal 2024 ended July 31, 2023. Key Milestones during Fiscal Q1 2024 and to date:Appointed FJ Medical as distributor for the Nordic countries of Denmark, Sweden, Norway and Finland; Engaged MedPhy Technologies as importer and distributor of MyoVista® wavECG™ and related supplies in India; Selected by PanaceaFlo Ltd to be used in its frontline cardiovascular risk screening evaluation study in Ireland. ...

Continue reading

iPower Reports Fiscal Fourth Quarter and Full Year 2023 Results

– Fiscal 2023 Revenue up 12% to Record $88.9 Million, with Cash Flow from Operations of $9.2 Million – – iPower Management to Host Conference Call Today at 4:30 p.m. Eastern Time – DUARTE, Calif, Sept. 14, 2023 (GLOBE NEWSWIRE) — iPower Inc. (Nasdaq: IPW) (“iPower” or the “Company”), a tech and data-driven online retailer and supplier of consumer home and garden products, as well as a provider of value-added ecommerce services, today announced financial results for its fiscal fourth quarter and full fiscal year ended June 30, 2023. Fiscal Q4 2023 Results vs. Year-Ago Quarter Total revenue increased 6% to $23.4 million as compared to $22.1 million. Gross profit remained flat at $9.1 million, with gross margin of 38.7% as compared to 41.2%. Net loss attributable to iPower was $3.0 million or $(0.10) per...

Continue reading

Rezolute Reports Full Year Fiscal 2023 Results and Highlights Company Progress

Planning to initiate Phase 3 Study for RZ358 (“sunRIZE study”) in the fourth quarter of 2023 REDWOOD CITY, Calif., Sept. 14, 2023 (GLOBE NEWSWIRE) — Rezolute, Inc. (Nasdaq: RZLT), a clinical-stage biopharmaceutical company dedicated to developing transformative therapies with the potential to disrupt treatment paradigms for devastating metabolic diseases, today announced its financial results for the fourth quarter and full fiscal year ended June 30, 2023. “We are delighted that we are poised to initiate sunRIZE – our Phase 3 study of RZ358, which we hope will bring us one step closer to making this therapy available to patients and their families suffering from congenital hyperinsulinism. We are also anticipating results from our Phase 2 study of RZ402 in the first quarter of 2024, where we hope to demonstrate the safety and proof-of-concept...

Continue reading

eGain Reports Fiscal 2023 Fourth Quarter and Full Year Financial Results

SUNNYVALE, Calif., Sept. 14, 2023 (GLOBE NEWSWIRE) — eGain (Nasdaq: EGAN), a leading knowledge platform for customer engagement, today announced financial results for its fiscal 2023 fourth quarter and full year ended June 30, 2023. “We finished the year strong, delivering top and bottom-line results ahead of our guidance and street consensus,” said Ashu Roy, eGain’s CEO. “After a tough fiscal 2023 when deals stalled in our pipeline due to the difficult macro environment, we are now seeing many of those deals re-engaging and new RFPs launching with urgency and intent. Generative AI is rejuvenating interest in knowledge management platforms, and this will drive demand for our products in fiscal 2024.” Fiscal 2023 Fourth Quarter Financial HighlightsTotal revenue was $24.6 million, up 5% year over year. SaaS revenue was $22.7 million,...

Continue reading

Dynagas LNG Partners LP Reports Results For the Three and Six Months Ended June 30, 2023

ATHENS, Greece, Sept. 14, 2023 (GLOBE NEWSWIRE) — Dynagas LNG Partners LP (NYSE: “DLNG”) (“the “Partnership”), an owner and operator of liquefied natural gas (“LNG”) carriers, today announced its results for the three and six months ended June 30, 2023. Half year Highlights:Net Income and Earnings per common unit (basic and diluted) of $24.0 million and $0.50, respectively; Adjusted Net Income(1) of $12.4 million and Adjusted Earnings(1) per common unit (basic and diluted) of $0.18; Adjusted EBITDA(1) $46.6 million; 95.8% fleet utilization(2).Quarter Highlights:Net Income and Earnings per common unit (basic and diluted) of $14.4 million and $0.31, respectively; Adjusted Net Income(1) of $5.8 million and Adjusted Earnings(1) per common unit (basic and diluted) of $0.08; Adjusted EBITDA(1) $23.0 million; 91.7% fleet utilization(2); Declared...

Continue reading

Frequency Electronics, Inc. Announces First Quarter Fiscal Year 2024 Financial Results

MITCHEL FIELD, N.Y., Sept. 14, 2023 (GLOBE NEWSWIRE) — Frequency Electronics, Inc. (“FEI” or the “Company”) (NASDAQ-FEIM) is reporting revenues for the first quarter ended July 31, 2023, of approximately $12.4 million, compared to revenues of $8.2 million, for the first quarter of fiscal year 2023, ended July 31, 2022. Operating income for the first quarter of fiscal year 2024 was $2.1 million compared to an operating loss of $3.1 million for the same period of fiscal year 2023. Net Income from operations was $2.0 million or $0.22 per diluted share compared to a net loss from operations of $3.1 million or ($0.33) per diluted share for the first quarter of fiscal year 2023 FEI President and CEO, Tom McClelland commented, “In the first quarter of fiscal year 2024 we continued to see the results of the cost cutting efforts and management...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.